US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

109.80

-0.6684-0.61%

Post-market: 109.76-0.0402-0.04%19:30 EDT

Volume:10.03K

Turnover:1.10M

Market Cap:92.23M

PE:- -

High:111.43

Open:111.43

Low:108.92

Close:110.47

52wk High:126.40

52wk Low:62.72

Shares:840.00K

Float Shares:840.00K

Volume Ratio:1.58

T/O Rate:1.19%

Dividend:0.22

Dividend Rate:0.20%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Leerink Partners Remains a Hold on Amgen (AMGN)

US Judge Steps Aside in Dispute over Hawaii Energy Settlement

Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

Update: US Equity Indexes, Crude Oil Prices Mixed in Midday Trading

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement

Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi

Truist sees ‘significant positive readthrough’ for Maze from Vertex data

Maze jumps 25% to $27.99 after Vertex kidney disease data

Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal

Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial

Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BIB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":109.8002,"timestamp":1790971200000,"preClose":110.4686,"halted":0,"volume":10030,"hourTrading":{"tag":"盘后","latestPrice":109.76,"preClose":109.8002,"latestTime":"19:30 EDT","volume":14,"amount":1537.8616,"timestamp":1790983802987,"change":-0.0402,"changeRate":-0.000366,"amplitude":0},"delay":0,"changeRate":-0.006050588130925813,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"Market Closed","change":-0.6684,"latestTime":"10-02 16:00:00 EDT","open":111.43,"high":111.43,"low":108.9201,"amount":1099807.6543,"amplitude":0.02272,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":110.4686,"sharesOutstanding":1040000,"nav":110.3888,"aum":92726592,"dividendRate":0.002001,"bidAskSpread":0.002593,"preHourTrading":{"tag":"盘前","latestPrice":110.54,"preClose":110.4686,"latestTime":"08:34 EDT","volume":2,"amount":221.14,"timestamp":1790944495236,"change":0.0714,"changeRate":0.000646,"amplitude":0.000543},"postHourTrading":{"tag":"盘后","latestPrice":109.76,"preClose":109.8002,"latestTime":"19:30 EDT","volume":14,"amount":1537.8616,"timestamp":1790983802987,"change":-0.0402,"changeRate":-0.000366,"amplitude":0},"volumeRatio":1.5765482081823077,"impliedVol":0.476,"impliedVolPercentile":0.6534},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.5765482081823077,"shares":840000,"dividePrice":0.2197,"high":111.43,"amplitude":0.02272,"preClose":110.4686,"low":108.9201,"week52Low":62.72,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":109.8002,"eps":0,"divideRate":0.002001,"volume":10030,"delay":0,"ttmEps":0,"open":111.43,"prevYearClose":79.7794,"prevWeekClose":114.4199,"prevMonthClose":115.4524,"prevQuarterClose":115.4524,"fiveDayClose":114.4199,"twentyDayClose":121.9076,"sixtyDayClose":108.4938},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-09-23","symbol":"BIB","amount":0.082554,"announcedDate":"2026-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-23","defaultRemindTime":1790170200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-23","currency":"USD","dateTimestamp":1790136000000,"payDate":"2026-09-29"},{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669463318","title":"Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463318?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:31","pubTimestamp":1790238660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.8% to 5.59 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.2% and Amgen Inc. remained unchanged.Trading volume totaled 52.8 million shares, compared to the 50-day average of 85.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1983299246.USD","LU2468319806.SGD","BK4585","BK1515","BK4599","BK1589","IBB","BIB","PBE","LU2112291526.USD","AMGN","BK4566","PJP","LU0320765992.SGD","BK4581","IE00B4R5TH58.HKD","HK0000165453.HKD","LU1061106388.HKD","BK1191","LU0889565916.HKD","IE00BZ08YT58.USD","LU2089984988.USD","IE0002141913.USD","IE00BZ08YS42.EUR","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0058720904.USD","BK4534","BK4588","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","TBXU","BBH","LU0109394709.USD","LU0289739699.SGD","BK4533","IE00BJJMRZ35.SGD","01177","SG9999001440.SGD","LU1571399168.USD","LU1057294990.SGD","BK4139","LU2242652126.USD","IE00BFTCPJ56.SGD","BK1521","IE00BZ08YR35.GBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669381451","title":"Leerink Partners Remains a Hold on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669381451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669381451?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:15","pubTimestamp":1790226924,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Amgen. The company’s shares closed yesterday at $406.09. In addit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4599","LU2242652126.USD","LU2468319806.SGD","SG9999001440.SGD","LU2112291526.USD","BIB","BBH","LU1023059063.AUD","BK4585","PBE","LU1983299246.USD","BK4139","PJP","AMGN","LU0889565916.HKD","LU1571399168.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","TBXU","IBB","IE00B4R5TH58.HKD","IBBQ","BK4581","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4533","BK4534","BK4588","LU0289739699.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843952","title":"US Judge Steps Aside in Dispute over Hawaii Energy Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843952","media":"Reuters","labels":["policyRegulatory","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843952?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:00","pubTimestamp":1790197259,"startTime":"0","endTime":"0","summary":"US judge steps aside in dispute over Hawaii energy settlementSept 23 (Reuters)-A federal judge in Hawaii has disqualified himself from hearing a dispute over whether a decades-old price-fixing settlem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEXU","TRUN","LU0234570918.USD","LU2468319806.SGD","BK4201","BBH","LU0098860793.USD","MEDI","LU0122376428.USD","TMED","LU2129689605.HKD","LU0256863811.USD","LU0149725797.USD","IYE","BMED","IBB","LU0265550359.USD","LU0965509010.AUD","FENY","LU0265550946.USD","LU0640476718.USD","XLE","VDE","IBBQ","IGE","TBXU","DIG","IE0002270589.USD","GILD","LU0162691827.USD","LU0861579265.USD","LU1929549753.HKD","LU0300736062.USD","GXPE","FTXN","BIB","ERX","LU0456854461.SGD","SG9999002521.SGD","DRLL","BK4588","CVX","BK4559","IE00B3T34201.USD","LU0868494708.USD","WEEI","IE00B19Z3B42.SGD","IXC","LU1037948541.HKD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669090435","title":"Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2669090435","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669090435?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:01","pubTimestamp":1790193684,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics names Solid Biosciences CEO Bo Cumbo to boardStoke Therapeutics appointed Bo Cumbo to its board.Edward Kaye retired as a director; he served on the board since 2017 and was CEO from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL9kWWfM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IBBQ","IE00BFTCPJ56.SGD","SLDB","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU2468319806.SGD","STOK","MEDI","IE00BJT1NW94.SGD","BIB","LU2087621335.USD","LU0320765992.SGD","LU0965509101.SGD","LU0122379950.USD","BK4578","BMED","IE0009355771.USD","IE00BSNM7G36.USD","LU1674673691.USD","BK4550","LU0859254822.USD","LU1674673428.USD","SRPT","LU1778281490.HKD","TMED","LU1934455277.USD","LU0882574055.USD","IBB","TBXU","BK4585","BK4139","GILD","LU1066053197.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU2112291526.USD","BK4588","LU0889565916.HKD","LU2324357040.USD","LU0109394709.USD","LU1061106388.HKD","SRPU","BBH","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646482","title":"Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646482","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669646482?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:00","pubTimestamp":1790175600,"startTime":"0","endTime":"0","summary":"Amgen rebounds to $410.24 as dazodalibep and IMDELLTRA strengthen the pipeline while $418.73 becomes the next technical test.\n","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262182585-stocks-amgen-stock-forecast-pipeline-410-breakout-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZNH","ORR","PBE","TSLG","LU1061106388.HKD","BGSX","AZN","TSLT","TSL","BIB","TSLP","TSLI","LU2242652126.USD","LU0868494617.USD","07766","ELOL","LU2468319806.SGD","TSLQ","AMGN","09766","09366","BBH","TSLL","TSII","07366","TLA","LU1571399168.USD","PJP","IE0009355771.USD","TSDD","TSLZ","BK7095","ORR.AU","TSLY","TEST","LU1983299246.USD","LU2237443549.SGD","TESC","TSLO","IBB","TSYY","IE0002141913.USD","TBXU","TSLR","TSLS","CRSH","TSLW","IBBQ","TESL","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","BK4139","LU0757428866.USD","LU2417539215.USD","VERX","LU0289739699.SGD","LU1559883803.SGD","SG9999001176.SGD","LABU","BBH","LU0109394709.USD","NKTR","IE0002270589.USD","VRTX","BK4585","XBI","GNMX","XLV","IBB","LU2362541513.USD","LU0256863811.USD","BIB","LU0234570918.USD","SG9999001176.USD","BK4533","LU0823416689.USD","TBXU","IBBQ","LU0061475181.USD","IDNA","LU2237438978.USD","LU0417517546.SGD","IE0002141913.USD","KYMR","LU0432979614.USD","BK4007","LU1674673428.USD","IE00BZ9MQY76.HKD","LU2324357040.USD","HCSG","LU2089984988.USD","LU2362541273.HKD","PBE","BK4023","IE00BJJMRZ35.SGD","LU1035775433.USD","LU1069344957.HKD","IE00B19Z3B42.SGD","IE00B894F039.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","IE00B19Z3B42.SGD","LABU","IE00BZ9MQY76.HKD","BBH","IBBQ","IE00B2B36J28.USD","PBE","VRTX","XLV","LU2506952170.USD","BK4139","FFTY","IE00BJJMRZ35.SGD","LU2456880835.USD","LU0823417737.USD","IBB","LU2462157665.USD","TBXU","IE0002270589.USD","SG9999001176.SGD","BK4567","LU0823417653.USD","SGXZ57979304.SGD","LU1854103824.USD","XBI","IE0009355771.USD","BIB","VERX","LU2506952097.USD","LU1585245621.USD","LU0823416689.USD","LU0234570918.USD","GNMX","ANAB","LU1035775433.USD","BK4583","LU2089984988.USD","LU0289739699.SGD","HCSG","LU0757428866.USD","LU0079474960.USD","LU1815336091.USD","DGX","IDNA","IE00BJT1NW94.SGD","SG9999001176.USD","LU2506951875.HKD","LU1093756325.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669999174","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633","url":"https://stock-news.laohu8.com/highlight/detail?id=2669999174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669999174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:36","pubTimestamp":1790134588,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU0234570918.USD","BK4585","IDNA","IE00B19Z9P08.USD","IBB","BIB","IE00BZ9MQY76.HKD","PBE","LU1674673428.USD","LU1069344957.HKD","LU2462157665.USD","LU0320765992.SGD","SG9999001176.USD","VRTX","LU0061475181.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","IE00B19Z3581.USD","GNMX","LU0889565916.HKD","LU0432979614.USD","LU1035775433.USD","LU2456880835.USD","IE00B19Z3B42.SGD","IE0002141913.USD","LU2417539215.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","SGXZ57979304.SGD","BK4588","LU1585245621.USD","TBXU","BBH","LU0109394709.USD","LU2362541273.HKD","IE00B19Z9Z06.USD","LU2237438978.USD","BK4139","SG9999013999.USD","IE00BFTCPJ56.SGD","BK4567","LU1093756325.SGD","IE00B894F039.SGD","LU1778281490.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171122","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:34","pubTimestamp":1790109240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.40% to $152.67 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 2.94% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.10% to $269.19, Pfizer Inc.  rose 0.68% to $27.93, and Abbott Laboratories  rose 0.69% to $103.69.Trading volume  remained 1.3 million below its 50-day average volume of 6.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU2089984988.USD","LU0859254822.USD","LU0114720955.EUR","LU1839511570.USD","SG9999015952.SGD","LU0882574055.USD","LU0122379950.USD","BK4139","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU0861579265.USD","LU1585245621.USD","LU2468319806.SGD","IBB","LU2324357040.USD","BK4588","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1674673691.USD","LU1061106388.HKD","LU1571399168.USD","LU1066053197.SGD","GILD","BK4566","IE0002270589.USD","LU1057294990.SGD","LU2357627491.SGD","BBH","BK4550","BK4578","LU1430594728.SGD","LU0823416689.USD","LU2112291526.USD","BK4585","LU1934455194.USD","LU1037948897.HKD","BK4583","MEDI","LU1778281490.HKD","SG9999015945.SGD","SG9999015986.USD","LU0109394709.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015978.USD","LU0965509010.AUD","TBXU","IE00B3T34201.USD","LU0965509101.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0965508806.USD","BK4568","LU1066051498.USD","IBBQ","TMED","LU2087621335.USD","BK4532","LU0234570918.USD","BMED","IE00B19Z3B42.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669577122","title":"Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669577122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669577122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:17","pubTimestamp":1790108275,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA salesOverviewUS pharmaceutical firm's fiscal Q4 revenue rose 6.4%, beating analyst expectationsCompany reported near break-even net loss for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL1N45E0WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","LU1061106388.HKD","LU0109394709.USD","LU0868494617.USD","AYTU","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","BK4581","TBXU","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE0002141913.USD","PBE","BK4534","IE00BJT1NW94.SGD","BK4007","LU2468319806.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","BK4139","LU1057294990.SGD","AMGN","PJP","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1023059063.AUD","BBH","BK4588","IE00B2B36J28.USD","LU2242646821.SGD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412656","title":"Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412656?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:47","pubTimestamp":1790095620,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Maze Therapeutics jumped after competitor Vertex Pharmaceuticals reported positive study results for its kidney disease drug, signaling strong commercial potential ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE0002141913.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","IDNA","LU0889565916.HKD","TBXU","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU0256863811.USD","LU1778281490.HKD","VRTX","LU1093756168.USD","LU1674673428.USD","BK4532","XBI","PBE","LU1430594728.SGD","BK4567","LU2324357040.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","LU1815336091.USD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0234570918.USD","LU1585245621.USD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU1069344957.HKD","GNMX","LU2456880835.USD","IBBQ","BK4023","VERX","LU2237438978.USD","IE0009355771.USD","LU0289739699.SGD","BK4585","IE00B2B36J28.USD","MAZE","LU1559883803.SGD","IE00B894F039.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669268991","title":"Update: US Equity Indexes, Crude Oil Prices Mixed in Midday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2669268991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669268991?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:35","pubTimestamp":1790094905,"startTime":"0","endTime":"0","summary":"(Updates with index/price moves and company/geopolitical news from the first paragraph.)US equity indexes traded mixed, with materials leading gainers and financials fronting decliners after midday on","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IJR","JEPQ","GSLC","ACWI","TECS","SFY","TOPT","MNQmain","IBBQ","AMGN",".IXIC","SDOW","VYM","DDM","IJH","SCHD","SQQQ","REZ","QQQE","SPDN","SPXL","SPY",".SPX","HIBS",".DJI","QQQJ","MYMmain","NDX","VTV","GPIQ","QLD","QQQA","TSPY","DJX","RSPN","GRNY","RSP","SSO","EQR","SPXU","QQQ","RSPU","TBXU","SPYV","DIA","BIB","NOBL","QQQY","DGRW","IVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669757123","title":"Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669757123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669757123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:20","pubTimestamp":1790090418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eledon Pharmaceuticals (ELDN), Viking Therapeutics (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU1061106388.HKD","LU0122379950.USD","IE00BJJMRZ35.SGD","BIB","LU0320765992.SGD","LABU","LU2242646821.SGD","LU2242652126.USD","LU0868494617.USD","LU2468319806.SGD","XLV","AMGN","BBH","LU0109394709.USD","LU2089984988.USD","BK4137","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU0128526141.USD","LU1571399168.USD","OZEM","IE00B4R5TH58.HKD","PJP","XBI","IE0009355771.USD","LU0029874061.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4585","LU1983299246.USD","BK4599","IBB","BK4533","IE0002141913.USD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","VKTX","BK4534","BK4588","LU0058720904.USD","HCSG","IE00BJT1NW94.SGD","IBBQ","ELDN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123184","title":"Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123184","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123184?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:15","pubTimestamp":1790090123,"startTime":"0","endTime":"0","summary":"• Amgen shares rose following positive Phase 3 OASIZ 301 trial results for dazodalibep.  \n• The company reported an annual revenue of $36.75B and a net profit of $7.71B.  \n• Analysts hold an average price target of $389.14 with a Hold rating.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262180812-market-movers-amgn-20260922","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4139","04332","LU0122379950.USD","IE0002141913.USD","PBE","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4599","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2112291526.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU2242646821.SGD","LU0058720904.USD","LU1057294990.SGD","LU1571399168.USD","PJP","LU2242652126.USD","BK4588","IE0009355771.USD","LU1983299246.USD","LU0320765992.SGD","BK4533","SG9999001440.SGD","LU2089984988.USD","BBH","AMGN","IBBQ","BK4566","LU0109394709.USD","BK4581","IBB","BK4585","TBXU","IE00BJT1NW94.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669821123","title":"Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669821123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669821123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:55","pubTimestamp":1790088920,"startTime":"0","endTime":"0","summary":"Citi says Amgen’s (AMGN) dazodalibep delivered “positive” Phase 3 results in systemic Sjogren’s, which reduces clinical risk for “a potentially und...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IE0002141913.USD","LU1057294990.SGD","LU0889565916.HKD","TBXU","BK4588","SG9999001440.SGD","LU1983299246.USD","LU0868494617.USD","PJP","PBE","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","BK4566","LU0122379950.USD","BK4533","LU1061106388.HKD","IBB","LU1023059063.AUD","LU2089984988.USD","BIB","AMGN","LU0058720904.USD","BK4534","BK4581","LU0320765992.SGD","IBBQ","LU2242646821.SGD","LU2468319806.SGD","LU1571399168.USD","IE0009355771.USD","LU0289739699.SGD","BK4585","BK4599","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128999","title":"Truist sees ‘significant positive readthrough’ for Maze from Vertex data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128999","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128999?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:30","pubTimestamp":1790087413,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill views Vertex’s (VRTX) positive Phase 2 topline data as a meaningful validation of APOL1 inhibition in classic APOL1-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IE00BZ9MQY76.HKD","IE0009355771.USD","LU0889565916.HKD","LU1674673428.USD","IE00B19Z9P08.USD","LU0757428866.USD","IE00B19Z3581.USD","BK4532","LU2089984988.USD","BBH","LU0256863811.USD","LU1559883803.SGD","BK4023","LU1778281490.HKD","TBXU","LU0061475181.USD","IE0002141913.USD","LU0823416689.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1585245621.USD","IDNA","IE00BJJMRZ35.SGD","GNMX","IE00B19Z3B42.SGD","PBE","IE0002270589.USD","LU1069344957.HKD","LU1093756168.USD","LU1093756325.SGD","BK4533","LU2362540622.SGD","LU2462157665.USD","LU1035775433.USD","IE00B894F039.SGD","LU0058720904.USD","IBBQ","VRTX","IE00B19Z9Z06.USD","LU1674673691.USD","BIB","LU0079474960.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0289739699.SGD","LU2362541513.USD","VERX","LU2456880835.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919128","title":"Maze jumps 25% to $27.99 after Vertex kidney disease data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919128","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:25","pubTimestamp":1790087125,"startTime":"0","endTime":"0","summary":"10:23 EDT Maze jumps 25% to $27.99 after Vertex kidney disease data Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","IE00B19Z3581.USD","LU0432979614.USD","IE00BZ9MQY76.HKD","VRTX","LU0256863811.USD","LU1093756168.USD","LU0889565916.HKD","IE00B894F039.SGD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU1674673428.USD","PBE","LU1559883803.SGD","LU0058720904.USD","SG9999013999.USD","BK4567","LU0234570918.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU2089984988.USD","BIB","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","BK4023","IE0002141913.USD","LU0079474960.USD","BK4533","IBB","LU2362541513.USD","TBXU","IBBQ","IE0002270589.USD","LU1778281490.HKD","IDNA","LU2456880835.USD","GNMX","BK4585","LU2236285917.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1585245621.USD","LU1815336091.USD","LU2417539215.USD","LU1093756325.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669470171","title":"Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669470171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669470171?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:48","pubTimestamp":1790084894,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen rises after autoimmune drug meets late-stage trial goal** Shares of drugmaker AmgenAMGN.Orise 2.4% to $402.69** Co says its experimental drug, dazodalibep, for Sjogren's diseasemet the main goalof reducing disease activity in a late-stage trial** Sjogren's disease is an autoimmune disorder that causes dryness of the eyes, mouth and other parts of the body, along with fatigue and chronic pain** Drug showed a statistically significant and clinically meaningful improvement at week 48; most side effects were mild to moderate** Co plans to present detailed results at an upcoming medical meeting** Including session's move, AMGN up 23.1% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","LU0122379950.USD","LU0889565916.HKD","BK4599","BK4534","LU2112291526.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","PJP","PBE","IBB","SG9999001440.SGD","BK4585","LU1983299246.USD","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","BIB","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147050","title":"Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147050","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147050?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:45","pubTimestamp":1790084715,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Amgen Inc::*AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026*AMGEN: DAZODALIBEP MEETS PRIMARY ENDPOI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSDcc0x9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","LU1061106388.HKD","LU0122379950.USD","IE00BJJMRZ35.SGD","BIB","LU0320765992.SGD","LU2242646821.SGD","LU2242652126.USD","LU0868494617.USD","LU2468319806.SGD","LU1023059063.AUD","AMGN","BBH","LU0109394709.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU1571399168.USD","PJP","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4585","LU1983299246.USD","BK4599","IBB","BK4533","IE0002141913.USD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","BK4534","BK4588","BK4581","LU0058720904.USD","IE00BJT1NW94.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147177","title":"Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147177?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:36","pubTimestamp":1790084178,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4534","LU0889565916.HKD","LU2468319806.SGD","LU2112291526.USD","BBH","LU1571399168.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","AMGN","PBE","BK4585","LU1983299246.USD","SG9999001440.SGD","IBB","LU0289739699.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IBBQ","TBXU","LU0868494617.USD","LU1057294990.SGD","LU2089984988.USD","LU0058720904.USD","LU0109394709.USD","LU0122379950.USD","BK4533","PJP","LU1061106388.HKD","LU2242646821.SGD","IE00BJT1NW94.SGD","BIB","BK4581","BK4599","BK4588","BK4139","LU1023059063.AUD","IE0009355771.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}